• Calpain-specific breakdown fragment in human drusen

    K. Orihara, M. Kobayashi-Otsugu, E. Nakajima, R.D. Walkup, D.J. Wilson, T.R. Shearer and M. Azuma

    Histol Histopathol (2024) 39: 165-175

  • An Autotaxin-Induced Ocular Hypertension Mouse Model Reflecting Physiological Aqueous Biomarker

    Shota Shimizu1, 2, Megumi Honjo1, Liu Mengxuan1, Makoto Aihara1

    1 Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo,

    2 Senju Laboratory of Ocular Science, Senju Pharmaceutical Co., Ltd., Kobe

    Investigative Ophthalmology & Visual Science

  • 医薬品業界において技術士が提供するソリューション 第3回 眼科薬の製剤開発と技術士

    山口正純

    千寿製薬株式会社

    PHARM TECH JAPAN Vol.40 No.3(2024)

  • 液垂れを低減する点眼ノズルの形状の開発

    藤本 高志、山口 正純、大久保 宏哉、高見 勇人

    あたらしい眼科　40（12）:1611~1616,2023©

  • アジマイシン点眼液1％の小児の結膜炎を対象とした特定使用成績調査

    山際 智充、坂本 祐一郎、末信 敏秀

    あたらしい眼科 40(11)：1469~1475,2023©

  • Survey of toxicity study packages and designs of intravitreal drugs approved in Japan

    Kotaro Yamada, Yoshinori Yamagiwa, Yu Haranosono

    Fundamental Toxicological Sciences. 2023; 10(6): 249-258.

  • Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis

    Eriko Kunikane1, Yusuke Orii2, Akiko Inoue1, Masaru Inatani2

    1 Senju Pharmaceutical Co., Ltd.

    2 University of Fukui

    Ophthalmol Ther (2023). https://doi.org/10.1007/s40123-023-00794-x

  • New Candidate Preservative in Ophthalmic Solution Instead of Benzalkonium Chloride: 1,3-Didecyl-2-methyl Imidazolium Chloride

    Takuya Iwasaki, Ryosuke Uchiyama, and Kazuto Nosaka

    Chemical and Pharmaceutical Bulletin 71(7) 552–557, 2023

  • Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study

    Yusuke Orii1, Eriko Kunikane2, Yutaka Yamada1, Masakazu Morioka1, Kentaro Iwasaki1, Shogo Arimura1,Akemi Mizuno2 and Masaru Inatani1

    1 Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan

    2 Senju Pharmaceutical Co., Ltd., Osaka 541-0048, Japan

    J. Clin. Med. 2023, 12, 4175. https://doi.org/10.3390/jcm12134175

  • A survey of on the use of genotoxicity and carcinogenicity testing packages for ophthalmic drug development

    Haruna Tahara,Yu Haranosono

    Fundamental Toxicological Sciences. 2023; 10(3): 105-112.

See more